Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Miller

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Molecular Pharmaceutics|May 29, 2012
A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeabilityJonathan M Miller, Avital Beig, Robert A Carr, et al.
Journal of Pharmaceutical Sciences|December 30, 2009
The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesteroneArik Dahan, Jonathan M Miller, Amnon Hoffman, et al.
Molecular Pharmaceutics|January 28, 2012
The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulationsJonathan M Miller, Avital Beig, Robert A Carr, et al.
Progress in Pediatric Cardiology|August 25, 2020
Severe cardiac dysfunction in a patient with multisystem inflammatory syndrome in children associated with COVID-19: Retrospective diagnosis of a puzzling presentation. A case reportDaniel Vari, Jonathan M Miller, Neil Rellosa, et al.
Drug Development and Industrial Pharmacy|March 3, 2012
Comparison of a rational vs. high throughput approach for rapid salt screening and selectionBenjamin M Collman, Jonathan M Miller, Christopher Seadeek, et al.
Molecular Pharmaceutics|May 16, 2017
Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water LayerNoa Fine-Shamir, Avital Beig, Moran Zur, et al.
Pediatric Quality & Safety|May 15, 2026
Improving Influenza Vaccination in the Pediatric Emergency DepartmentCourtney E Nelson, Shannon Baumer-Mouradian, Snezana Nena Osorio, et al.
American Journal of Health Promotion : AJHP|April 14, 2018
The Minne-Loppet Motivation Study: An Intervention to Increase Motivation for Outdoor Winter Physical Activity in Ethnically and Racially Diverse Elementary SchoolsJonathan M Miller, Julian Wolfson, Melissa N Laska, et al.
Electrophoresis|September 11, 2002
Semi-empirical relationships between effective mobility, charge, and molecular weight of pharmaceuticals by pressure-assisted capillary electrophoresis: applications in drug discoveryJonathan M Miller, Anthony C Blackburn, Yi Shi, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 30, 2017
Concomitant solubility-permeability increase: Vitamin E TPGS vs. amorphous solid dispersion as oral delivery systems for etoposideAvital Beig, Noa Fine-Shamir, Daniel Porat, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Molecular Pharmaceutics|May 29, 2012
A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeabilityJonathan M Miller, Avital Beig, Robert A Carr, et al.
Journal of Pharmaceutical Sciences|December 30, 2009
The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesteroneArik Dahan, Jonathan M Miller, Amnon Hoffman, et al.
Molecular Pharmaceutics|January 28, 2012
The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulationsJonathan M Miller, Avital Beig, Robert A Carr, et al.
Progress in Pediatric Cardiology|August 25, 2020
Severe cardiac dysfunction in a patient with multisystem inflammatory syndrome in children associated with COVID-19: Retrospective diagnosis of a puzzling presentation. A case reportDaniel Vari, Jonathan M Miller, Neil Rellosa, et al.
Drug Development and Industrial Pharmacy|March 3, 2012
Comparison of a rational vs. high throughput approach for rapid salt screening and selectionBenjamin M Collman, Jonathan M Miller, Christopher Seadeek, et al.
Molecular Pharmaceutics|May 16, 2017
Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water LayerNoa Fine-Shamir, Avital Beig, Moran Zur, et al.
Pediatric Quality & Safety|May 15, 2026
Improving Influenza Vaccination in the Pediatric Emergency DepartmentCourtney E Nelson, Shannon Baumer-Mouradian, Snezana Nena Osorio, et al.
American Journal of Health Promotion : AJHP|April 14, 2018
The Minne-Loppet Motivation Study: An Intervention to Increase Motivation for Outdoor Winter Physical Activity in Ethnically and Racially Diverse Elementary SchoolsJonathan M Miller, Julian Wolfson, Melissa N Laska, et al.
Electrophoresis|September 11, 2002
Semi-empirical relationships between effective mobility, charge, and molecular weight of pharmaceuticals by pressure-assisted capillary electrophoresis: applications in drug discoveryJonathan M Miller, Anthony C Blackburn, Yi Shi, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 30, 2017
Concomitant solubility-permeability increase: Vitamin E TPGS vs. amorphous solid dispersion as oral delivery systems for etoposideAvital Beig, Noa Fine-Shamir, Daniel Porat, et al.
Pageof 10